9.2 Oxygen, Glucose, and Assisted Medication Tasks
Key Takeaways
Titrate oxygen to the protocol target; patients at risk of hypercapnic respiratory failure may need a target of 88–92%. Inadequate breathing requires ventilation support, not just an oxygen mask.
Where state scope authorizes oral glucose, give it only when the patient can swallow and protect the airway, using the protocol dose.
Support ventilation during suspected opioid overdose. Use an authorized unit-dose intranasal product or auto-injector; NARCAN nasal spray repeat doses may be given every 2–3 minutes as needed.
Anaphylaxis needs urgent EMS care and airway support. An EMR may provide epinephrine only where state scope, training, and protocol authorize it; select the prescribed device by weight and product labeling.
Matching the Drug to the Emergency
Medication items on the EMR exam are really assessment-flow items. The scenario describes a problem — low oxygen, low blood sugar, an opioid overdose, cardiac chest pain, or anaphylaxis — and the right answer first checks whether the intervention is authorized for the responder, then links it to the assessment and protocol. Aspirin, oral glucose, and epinephrine for anaphylaxis below illustrate expanded state protocols; they are not a universal national EMR formulary. Patient Treatment and Transport is weighted at roughly 20-24% of the exam, so drill these as field sequences, not flash cards.
Oxygen is titrated, not poured on. The goal is an SpO2 of at least 94%, using an authorized device, such as a nasal cannula (1-6 L/min) or non-rebreather (10-15 L/min). State scope and agency protocol determine which additional devices and monitoring skills the responder may use. For a patient at risk of hypercapnic respiratory failure, such as some patients with COPD, the protocol may specify a controlled target of 88–92%. Titrate to the prescribed target and reassess; do not withhold necessary oxygen or ventilation. The key trap: if breathing is inadequate (too slow, too shallow, agonal), a mask is not enough — the patient needs assisted ventilation with a bag-valve mask. Oxygen never substitutes for opening and managing the airway.
Glucose, Naloxone, and Epinephrine
Oral glucose treats suspected hypoglycemia (the diabetic patient who is shaky, sweaty, confused, or combative). The dose is 15-25 g of gel or liquid, but the gatekeeper is airway safety: give it only if the patient is awake and can swallow and protect the airway. Do not give oral material to a patient who cannot reliably swallow or protect the airway, is actively seizing, or is vomiting. Continue airway support and request additional EMS care; confusion alone does not replace an assessment of swallowing and airway protection.
Naloxone (Narcan) reverses opioid overdose. The classic picture is depressed mental status, slow or absent breathing, and pinpoint pupils. The EMR priority order is to support ventilations with a BVM first, then give naloxone — commonly a 4 mg unit-dose intranasal product or an authorized auto-injector. For NARCAN nasal spray, use a new device for each repeat dose, which may be given every 2–3 minutes if needed, while continuing resuscitative support and following protocol. Naloxone is considered very safe across ages; the danger is forgetting that oxygenation, not the drug, is the immediate lifesaver.
Anaphylaxis is a true emergency: hives plus airway swelling, wheezing, or shock after an exposure. Where state scope and protocol permit, assist with the appropriate epinephrine auto-injector into the anterolateral thigh. Device selection follows weight and the product: EpiPen is 0.3 mg at 30 kg or more and EpiPen Jr is 0.15 mg at 15–30 kg. Smaller children need a product and dose specified by the treating clinician or protocol; do not infer that one pediatric device fits every child. Symptoms can rebound, so reassess and be ready to assist a second dose if protocol allows, request ALS early, and treat developing shock.
| Scenario clue | Intervention only if authorized for this responder | Critical safety check |
|---|---|---|
| Labored, adequate breathing, SpO2 90% | Oxygen to the protocol target; often 88–92% when at risk of hypercapnic respiratory failure | If breathing inadequate, ventilate with BVM instead |
| Diabetic, awake, confused, can swallow | Oral glucose 15-25 g | Never give oral material if cannot protect airway |
| Pinpoint pupils, RR 4, unresponsive | Ventilate, then authorized naloxone; follow product repeat interval | Oxygenation first; naloxone does not replace it |
| Chest pressure, no aspirin allergy | Aspirin 162-324 mg chewed | No active bleeding, no allergy |
| Hives + airway swelling after a sting | Use the prescribed epinephrine auto-injector and weight/product-specific dose, if authorized | Watch for rebound; request ALS early |
Reassess, Then Hand Off
A medication is never the end of the call. After any allowed intervention, reassess: Did breathing ease? Did mental status improve? Did the patient deteriorate or develop a new complaint? These observations become documentation and are repeated at handoff. "Assisted epinephrine 0.3 mg at 1412, breathing improved, no second dose" is far more useful than "gave the EpiPen."
Exam writers like choices that sound helpful but are incomplete — assist a medication but skip assessment, or wait for the ambulance while the patient worsens. Choose the action that manages immediate risk, uses the correct drug, dose, and route, stays in the EMR role, reassesses, and prepares the next clinician. Build a five-part habit for every medication item: assessment clue, scope limit, correct dose/route, reassessment finding, and the one-sentence handoff.
Two More Time-Critical Pictures
Cardiac chest pain and stroke deserve a closer look because both are time-critical and both have an EMR action. For suspected acute coronary syndrome, the patient describes chest pressure, heaviness, or discomfort, possibly with shortness of breath, nausea, sweating, or pain radiating to the arm or jaw. The EMR keeps the patient calm and at rest, gives oxygen when indicated by the protocol, and requests additional EMS resources early. Aspirin or assistance with nitroglycerin requires explicit state scope and agency authorization, as well as the relevant clinical safety checks. Definitive care is at the hospital.
Stroke is recognized with a screening tool. The classic mnemonic is FAST — Face droop, Arm drift, Speech difficulty, Time to call — and the expanded BE-FAST adds Balance loss and Eye/vision changes, which improves detection of posterior-circulation strokes that plain FAST can miss.
| Letter | Check | Positive finding |
|---|---|---|
| B | Balance | Sudden loss of balance or coordination |
| E | Eyes | Sudden vision loss or double vision |
| F | Face | One side droops when smiling |
| A | Arms | One arm drifts down when both are raised |
| S | Speech | Slurred, absent, or garbled speech |
| T | Time | Note time last known well; transport fast |
The single most important stroke data point the EMR captures is the time the patient was last known well, because it drives the hospital's treatment window. There is no EMR drug for stroke — the intervention is rapid recognition, airway and breathing support, and fast transport with that time recorded and reported.
A diabetic patient is sweaty, confused, but awake and able to swallow. State scope, training, and agency protocol authorize the EMR to give oral glucose. What is the correct action?
Withhold all treatment until the ambulance arrives
Administer 15-25 g of oral glucose after confirming the patient can protect the airway
Place an IV and give dextrose
Give the patient aspirin to raise blood sugar
An unresponsive patient has a respiratory rate of 4 and pinpoint pupils. Which sequence is best for the EMR?
Give oral glucose and wait
Administer aspirin, then transport
Give naloxone first and skip ventilation
Support ventilations with a BVM, then administer naloxone and reassess
Oxygen for a patient with adequate but labored breathing should be titrated to what target, and what changes if breathing becomes inadequate?
Always 100% by non-rebreather regardless of the reading
Titrate to the protocol target, with a controlled 88–92% target when at risk of hypercapnic respiratory failure; assist ventilation with a BVM if breathing becomes inadequate
No oxygen is ever needed if the patient is talking
A fixed 2 L/min for every patient with any complaint
Sections you finish are checked off in the contents.